EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for LONA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.8011
March 31, 2026 -1.732
December 31, 2025 -18.90
September 30, 2025 -1.676
June 30, 2025 -1.782
March 31, 2025 -0.2342
December 31, 2024 -3.858
September 30, 2024 -0.7462
June 30, 2024 -0.6998
March 31, 2024 -0.6873
December 31, 2023 -0.7159
September 30, 2023 -0.8664
June 30, 2023 -0.7789
March 31, 2023 -0.7336
Date Value
December 31, 2022 -0.7968
September 30, 2022 -0.5339
June 30, 2022 -0.646
March 31, 2022 -0.5581
December 31, 2021 -0.4371
September 30, 2021 -0.4201
June 30, 2021 -0.3755
March 31, 2021 -0.2478
December 31, 2020 -0.2371
September 30, 2020 -0.272
June 30, 2020 -0.0611
March 31, 2020 -0.0553
December 31, 2019 -0.3133
September 30, 2019 -0.0492

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. -0.2295
CNBX Pharmaceuticals, Inc. -0.0001
GB Sciences, Inc. --
Arvinas, Inc. 2.578
Fulcrum Therapeutics, Inc. -0.3433

EPS Diluted (Quarterly) Related Metrics